Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
The Best Country ETFs (2026)
Top Country ETFs
Best Equity Countries
| Country | 2026 | |
|---|---|---|
| 1 | Brazil | 22.33% |
| 2 | Taiwan | 15.28% |
| 3 | Japan | 12.02% |
| 4 | Belgium | 11.75% |
| 5 | United Kingdom | 7.42% |
Worst Equity Countries
| Country | 2026 | |
|---|---|---|
| 1 | Indonesia | -6.45% |
| 2 | United States | 0.24% |
| 3 | Italy | 2.58% |
| 4 | France | 2.99% |
| 5 | Saudi Arabia | 5.87% |
Source: justETF.com; As of 19/02/2026; Calculations in EUR based on the largest ETF of the respective index.
The Best Global Equity Markets (2026)
| Country Index | 4 Week Chart | 52 Week Low/High | in 2026 | 1 Month | 3 Months | 6 Months | 1 Year | 3 Years | ETFs |
|---|---|---|---|---|---|---|---|---|---|
| Brazil MSCI Brazil |  |  | 22.33% | 14.27% | 20.68% | 43.46% | 36.27% | 43.96% | 1 ETF |
| Taiwan MSCI Taiwan 20/35 |  |  | 15.28% | 6.54% | 23.52% | 28.83% | 32.16% | 96.62% | 1 ETF |
| Japan MSCI Japan |  |  | 12.02% | 4.86% | 16.55% | 17.42% | 21.06% | 58.88% | 2 ETFs |
| Belgium BEL20 |  |  | 11.75% | 5.98% | 14.90% | 18.13% | 30.84% | 52.20% | 1 ETF |
| United Kingdom FTSE 100 |  |  | 7.42% | 3.94% | 13.68% | 15.82% | 20.14% | 50.75% | 4 ETFs |
| Netherlands AEX® |  |  | 5.95% | 1.55% | 7.94% | 12.09% | 9.15% | 40.53% | 2 ETFs |
| Saudi Arabia MSCI Saudi Arabia 20/35 |  |  | 5.87% | -0.89% | 0.68% | 4.16% | -13.53% | 0.60% | 1 ETF |
| France CAC 40® |  |  | 2.99% | 3.47% | 5.73% | 5.67% | 6.73% | 24.70% | 2 ETFs |
| Italy FTSE MIB |  |  | 2.58% | 1.42% | 8.97% | 8.14% | 25.19% | 89.70% | 2 ETFs |
| United States S&P 500® |  |  | 0.24% | -2.18% | 1.96% | 6.79% | 0.06% | 57.17% | 5 ETFs |
| Indonesia MSCI Indonesia |  |  | -6.45% | -8.89% | -8.85% | -8.97% | -14.62% | -26.83% | 1 ETF |
Source: justETF.com; As of 19/02/2026; Calculations in EUR based on the largest ETF of the respective index.
The index selection is by no means a recommendation.